Ketoprofen

酮洛芬

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameKetoprofen
Drug Alias Name酮苯丙酸RicfenKetoprofenum苯酮苯丙酸Ketoprofeno +[38] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitorsLipoxygenase inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1Lipoxygenase
Therapy Area/IndicationsPeritendinitisSomatoform DisordersSprains and Strains +[27] 
Global Approved IndicationsOsteoarthritisArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited KingdomFrance
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[16] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHunan Paglan Pharmaceutical Co LtdShenzhen Pharmayi Pharmaceutical Technology Co LtdNew Valley University +[13] 
Inactive CompaniesApr Applied Pharma Research SaDompé farmaceutici SPAHandok Inc +[15] 
Active IndicationsPeritendinitisLow Back PainPain +[14] 
Inactive IndicationsSomatoform DisordersSprains and StrainsSoft Tissue Injuries +[13] 

Other Information

ATC CodeM01AE03M02AA10
Related LinksWikipediaDrugBankKEGG